ALLAKOS INC's ticker is ALLK and the CUSIP is 01671P100. A total of 118 filers reported holding ALLAKOS INC in Q1 2020. The put-call ratio across all filers is 0.87 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $11,358,000 | -39.5% | 133,045 | -18.7% | 0.37% | -42.9% |
| Q1 2021 | $18,783,000 | +2.5% | 163,645 | +25.0% | 0.65% | +0.3% |
| Q4 2020 | $18,331,000 | +249.5% | 130,937 | +103.3% | 0.64% | +226.9% |
| Q3 2020 | $5,245,000 | +13.3% | 64,397 | 0.0% | 0.20% | +11.9% |
| Q2 2020 | $4,628,000 | +61.5% | 64,397 | 0.0% | 0.18% | +35.4% |
| Q1 2020 | $2,865,000 | -57.9% | 64,397 | -9.8% | 0.13% | -49.4% |
| Q4 2019 | $6,808,000 | +609.2% | 71,396 | +484.9% | 0.26% | +511.9% |
| Q3 2019 | $960,000 | -9.3% | 12,207 | -50.0% | 0.04% | -2.3% |
| Q2 2019 | $1,058,000 | +7.0% | 24,414 | 0.0% | 0.04% | +7.5% |
| Q1 2019 | $989,000 | – | 24,414 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 270,965 | $12,055,000 | 6.94% |
| NEA Management Company, LLC | 2,268,188 | $100,912,000 | 5.27% |
| Fairmount Funds Management LLC | 178,662 | $7,949,000 | 4.82% |
| Redmile Group, LLC | 2,976,928 | $132,444,000 | 3.71% |
| Boxer Capital, LLC | 675,000 | $30,031,000 | 2.05% |
| Rock Springs Capital Management LP | 235,000 | $10,455,000 | 0.43% |
| Cormorant Asset Management, LP | 200,000 | $8,898,000 | 0.41% |
| RAMIUS ADVISORS LLC | 31,155 | $1,386,000 | 0.35% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 15,700 | $692,000 | 0.32% |
| Handelsinvest Investeringsforvaltning | 20,000 | $890,000 | 0.24% |